`Petitioner,
`v.
`AKER BIOMARINE ANTARCTIC AS,
`Patent Owner.
`
`IPR2020-01532
`U.S. Patent No. 9,644,169
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`PETITIONER’S DEMONSTRATIVES
`For Petitioner
`Lead Counsel: James F. Harrington, Esq. Reg. No: 44,741
`First Back Up Counsel: Michael I. Chakansky, Esq. Reg. No: 31,600
`Back Up Counsel: John T. Gallagher, Esq. Reg. No: 35,516
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`RIMFROST EXHIBIT 1172 SLIDE 01
`
`
`
`‘169 Patent Invalidity Grounds
`‘169 Petition, IPR2020-01532, Paper 2, p. 10
`
`TABLE I
`
`Ground
`
`Reference(s)
`
`Basis
`
`Claims
`Challenged
`
`1
`
`2
`
`Breivik II (EX1037)
`Catchpole (EX1009)
`Budziński (EX1008)
`Fricke (EX1010)
`Randolph (EX1011)
`
`Breivik II (EX1037)
`Catchpole (EX1009)
`Budziński (EX1008)
`Fricke (EX1010)
`Randolph (EX1011)
`Sampalis I (EX1012)
`
`35 U.S.C.
`
`1-5, 7-15, 17-20
`
`§ 103(a)
`
`35 U.S.C.
`
`§ 103(a)
`
`6, 16
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 02
`
`
`
`‘046 Patent Invalidity Grounds
`‘046 Petition, IPR2020-01533, Paper 2, pp. 10-11
`
`Ground
`
`References
`
`TABLE II
`
`Basis
`
`Claims Challenged
`
`1
`
`2
`
`3
`
`Breivik II (EX1037), Yoshitomi
`(EX1033), Budziński (EX1008),
`Fricke (EX1010),
`Bottino II (EX1038),
`Sampalis I (EX1012)
`
`Breivik II (EX1037), Yoshitomi
`(EX1033), Budziński (EX1008),
`Fricke (EX1010),
`Bottino II (EX1038),
`Randolph (EX1011)
`
`Breivik II (EX1037), Yoshitomi
`(EX1033), Budziński (EX1008),
`Fricke (EX1010),
`Bottino II (EX1038),
`Randolph (EX1011),
`Sampalis I (EX1012)
`
`35 U.S.C. §103(a)
`
`1-10
`
`35 U.S.C. §103(a)
`
`11, 12
`
`35 U.S.C. §103(a)
`
`13-19
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 03
`
`
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 04
`
`
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 05
`
`
`
`SELECT CLAIM LIMITATIONS AND PRIOR ART
`
`See, e.g., ‘169 Petition, Claim Chart, IPR2020-01532, Paper 2, pp. 69-89; ‘046 Petition, Claim Chart, IPR2020-
`01533, Paper 2, pp. 69-88; ‘169 Tallon Dec., EX1006 ¶¶ 435-501; ‘046 Tallon Dec., EX1006 ¶¶ 414-526.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 06
`
`
`
`SELECT CLAIM LIMITATIONS AND PRIOR ART [CONTINUED]
`
`See, e.g., ‘169 Petition, Claim Chart, IPR2020-01532, Paper 2, pp. 69-89; ‘046 Petition, Claim Chart, IPR2020-
`01533, Paper 2, pp. 69-88; ‘169 Tallon Dec., EX1006 ¶¶ 435-501; ‘046 Tallon Dec., EX1006 ¶¶ 414-526.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 07
`
`
`
`PATENT OWNER ADMITS THAT MANY CLAIM LIMITATIONS
`WOULD HAVE BEEN KNOWN TO A POSITA
`
`• Patent Owner, who in previous IPRs had vigorously argued that certain of
`its patents’ claim limitations were not obvious, now argues in order to fill
`in the gaps in its reduction to practice argument that these same patent
`claim limitations would have been obvious to a POSITA. ‘169 POR,
`Paper 9, pp. 24-35; ‘046 POR, Paper 9, pp. 25-38.
`
`• Patent Owner and its experts rely on the testimony of Petitioner’s expert
`Dr. Tallon’s to support the obviousness of these claim limitations. See,
`‘169 Tilseth Dec., EX2001 at ¶ 17; ‘169 Jaczynski Dec., EX2015 at ¶¶ 25-
`30; ‘046 Tilseth Dec., EX2001 at ¶ 17; ‘046 Jaczynski Dec., EX2015 at ¶¶
`24-29.
`
`• Patent Owner’s expert Dr. Jaczynski agreed at his deposition that these
`claim limitations would have been obvious to a POSITA. Jaczynski Dep.
`EX1170, pp. 44-47, 56-58, 61-65.
`
`See ‘169 Petitioner’s Reply, Paper 15, pp. 12-13, 17-18; ‘046 Petitioner’s Reply, Paper 15, 1, pp. 12-13, 17-18;
`and ‘169 Tallon Reply Dec., EX1086, ¶¶ 24-27, pp. 12-16; ‘046 Tallon Reply Dec., EX1086, ¶¶ 13, 25-28, pp.
`14-17.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 08
`
`
`
`SELECT PATENT OWNER’S ‘169 POSITA ADMISSIONS FOR ANTEDATION
`
`‘169 Tallon Reply Dec., EX1086, ¶ 26, pp. 14-15.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 09
`
`
`
`SELECT PATENT OWNER’S ‘046 POSITA ADMISSIONS FOR ANTEDATION
`
`‘046 Tallon Reply Dec., EX1086, ¶ 27, pp. 15-16.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 10
`
`
`
`COLLATERAL
`ESTOPPEL APPLIES
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 11
`
`
`
`‘169 AND ‘046 PATENTS FAMILY CHART
`
`‘169 Petition, Paper 2 at 11; ‘046 Petition, Paper 2 at 11; ‘169 Tallon Dec., EX1006, ¶ 32, p. 23; ‘046 Tallon Dec., EX1006, ¶ 33, p.
`24. Since the ‘169 and ‘046 Petitions were filed, all claims of the ‘453 patent (65 claims), 752 patent (20 claims) and ‘765 patent
`(48 claims) have been cancelled.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 12
`
`
`
`COLLATERAL ESTOPPEL APPLIES
`• The Board previously relied on all references in finding
`five other “krill oil” patents in the same family as the
`‘169 patent and the ‘046 patent unpatentable, with the
`exception of Budziński and its disclosure of krill meal
`storage for at least 13 months. Exhibits 1103-1104,
`1129, 1157-1159.
`
`• The inclusion of an intuitive and common sense
`storage limitation of 1-24 and 1-36 months does not
`materially alter the question of the ‘169 patent’s and
`the ‘046 patent’s unpatentability or the Board’s
`previous analysis of the prior art.
`
`See ‘169 Petition, IPR2020-01532, Paper 2, pp. 39-42; ‘046 Petition, IPR2020-01533, Paper 2, pp. 38-40;
`‘169 Petitioner’s Reply, Paper 15, pp. 6-7; ‘046 Petitioner’s Reply, Paper 15, pp. 6-7.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 13
`
`
`
`THE BOARD APPLIED ALL THE ‘169 IPR & THE ‘046 IPR
`REFERENCES IN EARLIER IPRS, EXCEPT FOR BUDZIŃSKI
`
`‘169 patent
`(2020-
`01532)
`
`‘046 patent
`(2020-
`1553)
`
`√
`
`√
`√
`√
`√
`
`√
`
`Catchpole
`
`Breivik II
`Sampalis I
`Randolph
`Fricke
`
`Budziński
`
`Yoshitomi
`Bottino II
`Breivik I
`
`√
`√
`√
`√
`
`√
`
`√
`√
`
`‘453 patent
`(2018-
`01178);
`(2018-
`01179)
`√
`
`√
`√
`√
`√
`
`√
`√
`
`‘877 patent
`(2017-
`00746)
`
`‘765 patent
`(2018-
`00295)
`
`‘905 patent
`(2017-
`00745)
`
`‘752 patent
`(2018-
`01730)
`
`√
`
`√
`√
`√
`√
`
`√
`
`√
`
`√
`
`√
`
`√
`
`√
`
`√
`
`√
`
`√
`
`See ‘169 Petition, IPR2020-01532, Paper 2, pp. 39-42; ‘046 Petition, IPR2020-01533, Paper 2, pp. 38-40;
`‘169 Petitioner’s Reply, Paper 15, pp. 6-7; ‘046 Petitioner’s Reply, Paper 15, pp. 6-7; see also ‘169 Tallon
`Dec., EX1006, ¶¶ 33-34 & p.23; ‘046 Tallon Dec., EX1006, ¶¶ 34-35 & p.24.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 14
`
`
`
`EXAMPLES OF CLAIM
`LIMITATIONS ALREADY
`FOUND OBVIOUS IN
`PRIOR IPRS.
`
`‘877 PATENT IPR: FWD All
`Claims Obvious (EX1104); affirmed,
`Aker Biomarine Antarctic AS v.
`Rimfrost AS, 2019 U.S. App. LEXIS
`29656 (EX1154).
`
`‘453 PATENT IPRs: FWDs All
`Claims Obvious (EX1157 &
`EX1158).
`
`See ‘169 Tallon Dec., EX1006 at ¶ 34 & Appendix F, p.0317; ‘169 Petition, Paper 2, p. 41; see also ‘046 Petition,
`Paper 2, p. 40; ‘046 Tallon Dec., EX1006 at ¶ 35.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 15
`
`
`
`EXAMPLES OF CLAIM
`LIMITATIONS ALREADY
`FOUND OBVIOUS IN
`PRIOR IPRS
`(CONTINUED).
`
`‘877 PATENT IPR: FWD All
`Claims Obvious (EX1104); affirmed,
`Aker Biomarine Antarctic AS v.
`Rimfrost AS, 2019 U.S. App. LEXIS
`29656 (EX1154).
`
`‘453 PATENT IPRs: FWDs All
`Claims Obvious (EX1157 &
`EX1158).
`
`See ‘169 Tallon Dec., EX1006 at ¶ 34 & Appendix F, p.0317; ‘169 Petition, Paper 2, p. 41; see also ‘046
`Petition, Paper 2, p. 40; ‘046 Tallon Dec., EX1006 at ¶ 35.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 16
`
`
`
`EXAMPLES OF
`CLAIM
`LIMITATIONS
`ALREADY FOUND
`OBVIOUS IN
`PRIOR IPRS.
`
`‘877 PATENT IPR: FWD
`All Claims Obvious
`(EX1104); affirmed, Aker
`Biomarine Antarctic AS v.
`Rimfrost AS, 2019 U.S. App.
`LEXIS 29656 (EX1154).
`
`‘453 PATENT IPRs: FWDs
`All Claims Obvious
`(EX1157 & EX1158).
`
`See ‘046 Petition, Paper 2, p. 40; ‘046 Tallon Dec., EX1006 at ¶ 35; see also ‘169 Tallon Dec., EX1006 at ¶ 34
`& Appendix F, p.0317; ‘169 Petition, Paper 2, p. 41.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 17
`
`
`
`EXAMPLES OF
`CLAIM
`LIMITATIONS
`ALREADY FOUND
`OBVIOUS IN
`PRIOR IPRS.
`
`‘877 PATENT IPR: FWD
`All Claims Obvious
`(EX1104); affirmed, Aker
`Biomarine Antarctic AS v.
`Rimfrost AS, 2019 U.S. App.
`LEXIS 29656 (EX1154).
`
`‘453 PATENT IPRs: FWDs
`All Claims Obvious
`(EX1157 & EX1158).
`
`See ‘046 Petition, Paper 2, p. 40; ‘046 Tallon Dec., EX1006 at ¶ 35; see also ‘169 Tallon Dec., EX1006 at ¶ 34
`& Appendix F, p.0317; ‘169 Petition, Paper 2, p. 41.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 18
`
`
`
`THE FEDERAL CIRCUIT AGREED WITH THE BOARD
`
`In affirming the Board’s Final Written Decisions in the ‘908 and ‘877 IPRs
`(IPR2017-00745 and IPR2017-00746, EX1103 & EX1104), the Federal Circuit
`noted that the Board’s findings were supported by substantial evidence:
`
`“After weighing the evidence, the Board found that the lipid components of
`krill oil can be extracted using any number of suitable solvents, that the
`proportions of the components could be varied in predictable ways, and
`that the resulting extracts could be blended to produce a final krill oil product.
`The Board credited expert testimony from Dr. Tallon that a person of skill
`could draw on an extensive body of established, industrial knowledge of
`methods and parameters that could be used to produce a stable product with
`known compositions. . . .”
`
`Aker Biomarine Antarctic AS v. Rimfrost AS, 2019-1097, 2019-1078, 2019 U.S.
`App. LEXIS 29656, at * 7 (Fed. Cir. Oct. 3, 2019) (emphasis added) (EX1154).
`
`See ‘169 Petition, IPR2020-01532, Paper 2, pp. 15-16; ‘046 Petition, IPR2020-01533, Paper 2, p. 16.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 19
`
`
`
`PATENT OWNER CANNOT TAKE POSITIONS
`INCONSISTENT WITH PRIOR ADVERSE JUDGMENT
`
`37 CFR § 42.73 Judgment.
`
`(d) Estoppel.
`
`***
`(3) Patent applicant or owner. A patent applicant or owner is
`precluded from taking action inconsistent with the adverse judgment,
`including obtaining in any patent:
`
`(i) A claim that is not patentably distinct
`from a finally refused or canceled claim . . . .
`
`See ‘169 Petition, IPR2020-01532, Paper 2, p. 42; ‘046 Petition, IPR2020-01533, Paper 2, p. 40.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 20
`
`
`
`“KRILL MEAL”
`
`“PROCESSED KRILL WITH REDUCED
`WATER CONTENT FROM WHICH OIL
`CAN BE EXTRACTED.”
`
`See ‘169 Petitioner’s Reply, Paper 15, p. 2; See ‘046 Petitioner’s Reply, Paper 15, p. 2; ‘‘169 Tallon
`Dec., EX1006, ¶¶ 134-152; ‘169 Tallon Reply Dec., EX1086, ¶¶ 34-43; ‘046 Tallon Dec., EX1006,
`¶¶ 138-156; ‘046 Tallon Reply Dec., EX1086, ¶¶ 38-47.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 21
`
`
`
`COMPLAINING OF PETITIONER’S APPROACH OF LOOKING TO THE
`PATENTS TO CONSTRUE THE TERM “KRILL MEAL” FIRST, PATENT
`OWNER IMPROPERLY STARTS ITS ANALYSIS OF WITH A DICTIONARY
`DEFINITION OF MEAL WHICH IS FOCUSED ON PLANT SEEDS NOT
`KRILL OR MARINE ANIMALS
`
`•
`
`“[Petitioner’s expert] Dr. Tallon’s analysis does not establish the plain and ordinary
`meaning of the term ‘meal’ as a starting point. The Cambridge English Dictionary
`defines meal as ‘a substance that has been crushed to make a rough powder,
`especially plant seeds crushed to make flour or for animal food.’ Ex. 2016”. ‘046
`POR, Paper 9 at 9; ‘169 POR, Paper 9 at 9.
`
`EX2016, p. 0001
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 22
`
`
`
`PETITIONER’S ‘169 IPR & ‘046 IPR “KRILL MEAL” CONSTRUCTION
`IS SUPPORTED BY INTRINSIC EVIDENCE; NOT DICTIONARIES
`
`PETITIONER’S PROPOSED
`CONSTRUCTION
`
`PATENT OWNER’S PROPOSED
`CONSTRUCTION
`
`processed krill with reduced
`water content from which oil
`can be extracted
`
`‘169 Tallon Dec., EX1006, ¶¶ 134-152;
`‘169 Tallon Reply Dec., EX1086, ¶¶ 34-43;
`‘046 Tallon Dec., EX1006, ¶¶ 138-156;
`‘046 Tallon Reply Dec., EX1086, ¶¶ 38-47.
`
`krill powder resulting from
`the processing of krill.
`
`‘169 POR, Paper 9, pp. 8-12.
`‘046 POR, Paper 9, pp. 8-11.
`
`See also ‘169 Petitioner’s Reply, Paper 15, p. 2; ‘046 Petitioner’s Reply, Paper 15, p. 2.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 23
`
`
`
`PATENT OWNER’S REMAINING ARGUMENTS FOR ITS “KRILL MEAL”
`CONSTRUCTION ARE EXPRESSLY REFUTED BY THE PATENTS’ SPECIFICATIONS
`
`Patent Owner’s two arguments in support of its construction of “krill meal” are meritless. ‘169
`Patent Owner’s Sur-Reply, Paper 18 at 6-7; ‘046 Patent Owner’s Sur-Reply, Paper 18 at 6-7.
`
`1. Patent Owner argues “[t]here is no example in the specification where ‘krill meal’ is used to
`describe whole krill that has simply been dehydrated.”
`
`• Petitioner’s construction does not require that the krill material be
`dehydrated, merely that it have a “reduced water content” and there are
`examples of the in the patents, including where, as admitted by Patent
`Owner, the krill is merely pressed to remove water.
`
`2. Patent Owner argues, that all of the krill meal examples from the patents relied on by
`Petitioner are the result of a being “processed by a step (e.g., pressing, grinding, etc.) that
`results in a krill product with a reduced particle size, i.e., a powder.” Thus, Patent Owner
`argues that krill meal must be a powder.
`
`• Reduced particle size does not necessarily result in a powder and the
`patents provide examples where it is not.
`‘169 Petitioner’s Reply, Paper 15, pp. 2-6; ‘046 Petitioner’s Reply, Paper 15, pp. 2-6; ‘169 Tallon Reply Dec.,
`EX1086 at ¶ 43; ‘169 Tallon Reply Dec., EX1086 at ¶ 47; see also ‘169 Tallon Reply Dec., EX1086 at ¶¶ 34-42;
`‘169 Tallon Reply Dec., EX1086 at ¶¶ 39-46; ‘169 Tallon Dec., EX1006 at ¶¶ 134-152; ‘046 Tallon Dec.,
`EX1006 at ¶¶ 138-156.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 24
`
`
`
`PATENT OWNER’S REMAINING ARGUMENTS FOR ITS “KRILL MEAL”
`CONSTRUCTION ARE EXPRESSLY REFUTED BY THE PATENTS’ SPECIFICATIONS
`[CONTINUED]
`“In some embodiments, freshly caught krill is wet pressed to obtain oil and
`meal. In some embodiments, the meal is then heated to a temperature of
`about 50° C. to about 100° C. for about 20 minutes to about an hour, 55
`preferably about 40 minutes to denature the proteins. In some embodiments,
`this material is then pressed to yield a press cake.”
`‘169 Patent, EX1001, 10:50-57, p. 0030 (emphasis supplied); ‘046 Patent,
`EX1001, 10:50-57, p. 0030 (emphasis supplied).
`
`“Fresh krill was pumped from the harvesting trawl directly into an indirect
`steam cooker, and heated to 90 C. Water and a small amount of oil were
`removed in a screw press before ethoxyquin (antioxidant) was added and
`the denatured meal was dried under vacuum at a temperature not exceeding
`80 C.”
`‘169 Patent, EX1001, 41:62-67, p. 0041 (emphasis supplied); ‘046 Patent,
`EX1001, 41:62-67, p. 0041 (emphasis supplied).
`
`See ‘169 Petitioner’s Reply, Paper 15 at 4; ‘046 Petitioner’s Reply, Paper 15 at 4; ‘169
`Tallon Dec. at ¶¶ 135, 141-142; ‘046 Tallon Dec. at ¶¶ 139, 145-146.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 25
`
`
`
`PATENT OWNER’S REMAINING ARGUMENTS FOR ITS “KRILL MEAL”
`CONSTRUCTION ARE EXPRESSLY REFUTED BY THE PATENTS’ SPECIFICATIONS
`[CONTINUED]
`
`Dr. Tallon testified:
`
`• “Krill materials formed by a screw press or a wet press
`[both described in the patent] and the resulting
`products including press cake [as described in the
`patent] are not powdered krill materials. Nor does the
`mere reduction in the particle size of krill materials
`equate to the formation of a krill powder.”
`
`‘169 Tallon Reply Dec., EX1086 at ¶ 43; ‘046 Tallon
`Reply Dec., EX1086 at ¶ 47.
`
`‘169 Petitioner’s Reply, Paper 15, pp. 2-6; ‘046 Petitioner’s Reply, Paper 15, pp. 2-6.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 26
`
`
`
`PATENT OWNER’S “KRILL MEAL” CONSTRUCTION IS INCONSISTANT
`WITH CLAIMS AS ITS PROVIDES FOR A KRILL MEAL AND THUS KRILL
`OIL WITHOUT ANY OF THE CLAIMED PHOSPHOLIPIDS
`
`Dr. Tallon testified:
`
`• “Notably, as construed by PO, PO’s ‘krill meal’ would
`by definition include completely dilipidated krill meal,
`i.e., a krill material without any lipids and, as such, no
`krill oil could be extracted from PO’s “krill meal” a
`material requirement of all the claims.”
`
`‘169 Tallon Reply Dec., EX1086 ¶ 38, fn.3; ‘046 Tallon Reply Dec., EX1086 ¶ 38, fn.3; see also
`‘169 Petitioner’s Reply, Paper 15, p. 2; ‘046 Petitioner’s Reply, Paper 15, p. 2.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 27
`
`
`
`NO REDUCTION TO PRACTICE
`BY PATENT OWNER
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 28
`
`
`
`EFFECTIVE FILING DATES OF
`‘169 and ‘046 PATENTS AND BREIVIK II
`
`• Effective Filing Date of ‘169 patent is January 28, 2008 (filing date of
`the ‘072 provisional, EX1002, as this is the first disclosure of ether
`phospholipids, which are required by all ‘169 patent claims). ‘169
`Petition, p. 11, ‘169 Tallon Dec., EX1006 at ¶¶ 31-32, 53-54.
`
`• Effective Filing Date of ‘046 patent is March 28, 2007 (filing date of the
`‘483 provisional, EX1005). ‘046 Petition, p. 11, ‘046 Tallon Dec.,
`EX1006 at ¶¶ 31-32.
`
`• Effective Filing Date of Breivik II is November 16, 2006 (filing date of
`the Breivik Provisional, EX1036). ‘169 Petition, p. 12, ‘169 Tallon Dec.,
`EX1006 at ¶ 242; ‘046 Petition, p. 12, ‘046 Tallon Dec., EX1006 at ¶¶
`226-238.
`
`• Patent Owner is alleging a Reduction to Practice prior to November 16,
`2006. ‘169 POR, Paper 9, p. 20; ‘046 POR, Paper 9, p. 20.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 29
`
`
`
`PATENT OWNER’S BURDEN TO PROVE ACTUAL
`REDUCTION TO PRACTICE
`
`• Patent Owner “bears the burden of establishing that its claimed invention is
`entitled to an earlier priority date than an asserted prior art reference.” In re
`Magnum Oil Tools, 829 F.3d 1364, 1375-76 (Fed. Cir. 2016).
`
`• Patent Owner must prove an actual reduction to practice before Breivik II’s
`priority date, “not [that Petitioner must] prove [Patent Owner] did not.” Apator
`Miitors ApS v. Kamstrup A/S, 887 F.3d 1293, 1297 (Fed. Cir. 2018).
`
`• To satisfy this burden, Patent Owner must demonstrate performance of a
`process meeting all limitations of the claimed invention and show the invention
`worked for its intended purpose. Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157,
`1169 (Fed. Cir. 2006).
`
`• Evidence of actual reduction to practice cannot rest on inventor testimony, and
`Patent Owner must proffer independent evidence corroborating Dr. Tilseth’s
`testimony. Medichem, 473 F.3d at 1170-72 (“Even the most credible inventor
`testimony is a fortiori required to be corroborated by independent evidence. . . .”).
`See‘169 Petitioner’s Reply, Paper 15, pp. 8-9; ‘046 Petitioner’s Reply, Paper 15, pp. 8-9.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 30
`
`
`
`PATENT OWNER’S ANTEDATION PROOFS ARE INSUFFICIENT
`
`A reduction to practice must meet all claim limitations:
`
`When the issue of priority concerns the antedating
`of a reference, the applicant is required to
`demonstrate . . . that the applicant was in
`possession of the later-claimed invention before
`the effective date of the reference.
`
`In re Steed, 802 F.3d 1311, 1316 (Fed. Cir. 2015)
`(emphasis added).
`
`See‘169 Petitioner’s Reply, Paper 15, p. 16; ‘046 Petitioner’s Reply, Paper 15, p. 16.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 31
`
`
`
`PATENT OWNER’S ANTEDATION PROOFS ARE INSUFFICIENT
`
`• Patent Owner’s argument that Breivik II does not qualify as prior art
`rests on the testimony of Dr. Tilseth, an inventor of both the ‘169
`patent and the ‘046 patent, that the invention recited in the patents was
`actually reduced to practice before Breivik II’s November 16, 2006 priority
`date. See, e.g., ‘169 and ‘046 POR, Paper 9, pp. 20-24.
`
`• Patent Owner failed to provide evidence corroborating, inter alia, that
`the krill had been “cooked,” and if “cooked,” heated to a temperature
`sufficient to “denature lipases and phospholipases” which as testified to
`by Dr. Tilseth, “occurs at the cooking stage”.
`
`• The absence of independent corroboration of Dr. Tilseth’s testimony
`that denaturation had occurred during the alleged krill processing “cooking
`stage” is fatal to Patent Owner’s attempt to antedate Breivik II.
`
`See‘169 Petitioner’s Reply, Paper 15, pp. 7-8; ‘046 Petitioner’s Reply, Paper 15, p. 7.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 32
`
`
`
`DR. TILSETH’S TESTIMONY THAT DENATURATION OCCURS
`DURING THE “COOKING STAGE” IS BASED SOLELY ON HIS
`INTERPRETATION OF SECTIONS 6.1-6.2 OF EX2003
`
`•
`
`“Sections 6.1 and 6.2 of Ex. 2003 (p. 0022-23) describe production and
`sampling of the krill meal during different production steps. The
`Atlantic Navigator was equipped with a standard compact fish meal
`factory. The krill meal was produced by a standard meal process where
`fresh krill is brought on board the ship, cooked, pressed and decanted, and
`then dried to provide the krill meal. The krill meal had a reduced particle
`size as compared to the fresh krill and was a powder as discussed below.
`Heating of the krill material sufficient to denature lipases and
`phospholipases occurs at the cooking stage prior to decanting/
`pressing. This meal is the same meal described in Example 1 of the ‘169
`Patent [‘046 Patent] (Ex. 1001 at pp. 0034-35) and Example 1 of the
`priority document U.S. Prov. Appl. 60/920,483 filed March 28, 2007 (Ex.
`1005 at pp. 0023-26).”
`
`‘169 Tilseth Dec., EX2001 at ¶ 8 (emphasis supplied); ‘046 Tilseth Dec., EX2001 at
`¶ 8 (emphasis supplied); see also ‘169 Petitioner’s Reply, Paper 15, pp. 9-10; ‘046
`Petitioner’s Reply, Paper 15, pp. 9-10.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 33
`
`
`
`THERE IS NO CORROBORATION SUPPORTING DR. TILSETH’S
`REDUCTION TO PRACTICE STORY THAT A DENATURED KRILL
`PRODUCT WAS FORMED
`
`Contrary to Patent Owner’s assertions, there is no reference to any
`cooking step, much less heating krill to a temperature sufficient to
`denature of krill lipases and phospholipases, in:
`• Sections 6.1-6.2 of EX2003
`• The remainder of EX2003
`• Dr. Tilseth’s meeting notes (EX2005 and EX2010)
`• K313 report (EX2013)
`• There is also no evidence, other than Dr. Tilseth’s suggestion,
`that the krill meal referenced in Example 1 was denatured.
`
`‘169 Petitioner’s Reply, Paper 15, pp. 9-13; ‘046 Petitioner’s Reply, Paper 15, pp. 9-13; see ‘169
`Tallon Reply Dec. at ¶¶ 13-14; ‘046 Tallon Reply Dec. at ¶¶ 14-15.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 34
`
`
`
`THERE IS NO CORROBORATION SUPPORTING DR. TILSETH’S
`REDUCTION TO PRACTICE STORY THAT A DENATURED KRILL
`PRODUCT WAS FORMED [CONTINUED]
`
`Dr. Tallon testified:
`
`•
`
`•
`
`“13. [14.] PO’s expert Tilseth relies solely on Sections 6.1 and 6.2 of EX2003
`(Tilseth Dec., EX2001 at ¶ 8) in order to support his only description of the
`production of a denatured krill meal aboard the Atlantic Navigator. However,
`notwithstanding PO’s expert to the contrary, neither Section 6.1 nor Section 6.2
`of EX2003 disclose or describe cooking or heating krill material denaturing
`lipases and phospholipases and/or describe or disclose a denatured krill
`product or meal. Neither does EX2003 provide any of the processing
`conditions used to prepare the meal. Again, even if EX2003 is taken as a whole, it
`does not disclose cooking or heating krill for denaturing lipases and phospholipases
`and/or describe or disclose a denatured krill product or meal.”
`
`“14. [15.] To be clear, none of exhibits accompanying Dr. Tilseth’s declaration,
`namely EX2002-EX2014, disclose ‘cooking’, a ‘cooking stage’, cooking
`temperature or duration, or the formation of a denatured krill product.”
`
`‘169 Tallon Reply Dec. at ¶¶ 13-14 (emphasis supplied), see also ¶¶ 29, 31; ‘046 Tallon Reply Dec. at ¶¶ 14-15
`(emphasis supplied), see also ¶¶ 29, 31.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 35
`
`
`
`THERE IS NO CORROBORATION SUPPORTING DR. TILSETH’S
`REDUCTION TO PRACTICE STORY THAT SECTIONS 6.1-6.2 DISCLOSE
`THE ALLEGED PROCESSES TO TREAT THE KRILL
`
`• Sections 6.1-6.2 (EX2003) do not disclose the
`operating conditions used to process the krill.
`
`• Sections 6.1-6.2 (EX2003) do not state that the krill
`was actually processed in a so-called “standard meal
`process,” or provide the operating conditions of such a
`process.
`
`• Sections 6.1-6.2 (EX2003) do not indicate that the krill
`fishing vessel was equipped with a “standard compact
`fish meal factory,” or explain what that phrase means.
`
`‘169 Petitioner’s Reply, Paper 15, pp. 9-10; ‘046 Petitioner’s Reply, Paper 15, pp. 9-10; see also ‘169 Tallon
`Reply Dec. at ¶¶ 29-30; ‘046 Tallon Reply Dec. at ¶ 28; see ‘169 Tilseth Dec., EX2001 at ¶ 8; ‘046 Tilseth Dec.,
`EX2001 at ¶ 8.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 36
`
`
`
`PATENT OWNER CANNOT INVOKE THE “RULE OF REASON”
`BY TAKING POSITIONS REGARDING DENATURATION THAT ARE
`CONTRARY TO THOSE MADE IN THE ‘169 AND ‘046 PATENTS
`
`The ‘169 and ‘046 patents state:
`“What is needed in the art are methods for processing krill that do not require transport of frozen
`•
`krill material over long distances and the products produced by those methods.” ‘169 Patent, EX1001,
`2:19-21; ‘046 Patent, EX1001, 2:17-19.
`
`•
`
`•
`
`•
`
`“The present invention provides methods to avoid decomposition of glycerides and phospholipids in krill
`oil and compositions produced by those methods. The product obtained by these new methods is virtually
`free of enzymatically decomposed oil constituents. The solution to the problem is to incorporate a
`protein denaturation step on fresh krill prior to use of any extraction technology. Denaturation can be
`achieved by thermal stress or by other means. After denaturation, the oil can be extracted by an optional
`selection of nonpolar and polar solvents including use of supercritical carbon dioxide.” ‘169 Patent,
`EX1001, 9:65-10:4 (emphasis supplied); ‘046 Patent, EX1001, 9:61-10:4 (emphasis supplied).
`
`“Krill oil extracted from denatured krill meal by supercritical fluid extraction even 19 months after
`production of meal contained virtually no decomposed phospholipids.” ‘169 Patent, EX1001, 11:3-6
`(emphasis supplied); ‘046 Patent, EX1001, 11:3-6 (emphasis supplied).
`
`“Fresh krill was pumped from the harvesting trawl directly into an indirect steam cooker, and heated to 90
`C. Water and a small amount of oil were removed in a screw press before ethoxyquin (antioxidant) was
`added and the denatured meal was dried under vacuum at a temperature not exceeding 80 C. After 19
`months storage in room temperature, a sample of the denatured meal was extracted in two steps with
`supercritical CO2 . . . .” ‘169 Patent, EX1001, 31:36-43 (emphasis supplied); ‘046 Patent, EX1001, 31:60-
`31:2 (emphasis supplied).
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 37
`
`
`
`INVOCATION OF THE “RULE OF REASON” DOES NOT FILL THE GAPS
`IN DR. TILSETH’S REDUCTION TO PRACTICE STORY
`
`The totality of the evidence proffered by Patent Owner and relied on by Dr.
`Tilseth fails to disclose that krill was heated or cooked to a temperature
`sufficient to denature krill lipases and phospholipases:
`• Sections 6.1-6.2 of EX2003
`• The entirety of EX2003
`• The entirety of EX2013
`• Dr. Tilseth’s meeting notes (EX2005, EX2010)
`• Any of the exhibits accompanying Dr. Tilseth’s Declaration
`• There is no evidence supporting Dr. Tilseth’s statement that the krill
`meal referenced in Example 1 was denatured.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 38
`
`
`
`INVOCATION OF THE “RULE OF REASON” DOES NOT FILL THE GAPS
`IN DR. TILSETH’S REDUCTION TO PRACTICE STORY
`
`• “The ‘rule of reason’ analysis does not alter the
`requirement of corroboration of an inventor's
`testimony. Brown v. Barbacid, 276 F.3d 1327,
`1335 (Fed. Cir. 2002). Evidence of the inventive
`facts must not rest alone on the testimony of the
`inventor himself.” Chen v. Bouchard, 347 F.3d
`1299, 1308 (Fed. Cir. 2003).
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 39
`
`
`
`INCONSISTENCIES REGARDING WHAT IS REPORTED IN
`EXHIBITS 2011 AND 2013
`
`EX2011, p. 0002
`
`EX2013, p. 0005
`
`“3150 kg krill flour”
`
`“3200 kg krill meal”
`
`“approximately 500 kg
`of phospholipids”
`
`“660 kg of crude
`lipids”
`
`starting
`material
`
`yield
`
`extract
`
`“not viscous”
`
`“high viscosity”
`
`conditions
`
`“lasted for (2) hours and
`was run at room
`temperature”
`
`“time and temperature
`. . . was unknown”
`
`‘169 Petitioner’s Reply, Paper 15, p. 15; ‘046 Petitioner’s Reply, Paper 15, p. 15.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 40
`
`
`
`STEMPEL DOES NOT OVERCOME THE ABSENCE OF
`ADEQUATE CORROBORATION OF DR. TILSETH’S
`REDUCTION TO PRACTICE STORY
`Stempel related to anticipation and simply held that a reference may be
`overcome as to a generic claim by showing priority to the species disclosed in
`the prior art reference. 241 F.2d 755, 758-59 CCPA 1957):
`
`In re Tanczyn put Stempel into proper context:
`
`•
`
`“We never intended by the language used in Stempel to authorize the
`overcoming of references by affidavits showing that the applicant had
`invented, prior to the reference date, a part, some parts or even a
`combination of parts, used to create an embodiment of his claimed
`invention. . . .”
`
`•
`
`* * *
`“The primary consideration is whether, in addition to showing what a
`reference shows, the affidavit also established possession of either the
`whole invention claimed or something falling within the claim, in the
`sense that the claim as a whole reads on it.”
`146 USPQ 298, 301-02 (CCPA 1965).
`‘169 Petitioner’s Reply, Paper 15, pp. 15-17; ‘046 Petitioner’s Reply, Paper 15, pp. 15-18.
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 41
`
`
`
`THE CASES CITED BY PATENT OWNER FAIL TO DEMONSTRATE
`THAT STEMPEL OVERCOMES THE ABSENCE OF ADEQUATE
`CORROBORATION OF DR. TILSETH’S REDUCTION TO PRACTICE STORY
`
`Petitioner has not argued Breivik II recites a species of a claimed genus.
`Patent Owner’s cases are limited to genus - species situations
`
`•
`
`In re Rainer, 390 F.2d 771, 774 (CCPA 1968) (anticipation/genus-
`species)
`
`(“The question is whether the species which have been reduced
`to practice suffice to provide a basis for a reasonable inference
`of possession of the generic invention. We do not believe
`appellants have shown the reasonableness of the inference in this
`case. . . . Appellants have made no attempt to show that generic
`applicability would be a reasonable inference from their
`experiments of record.”).
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 42
`
`
`
`•
`
`•
`
`THE CASES CITED BY PATENT OWNER FAIL TO DEMONSTRATE
`THAT STEMPEL OVERCOMES THE ABSENCE OF ADEQUATE
`CORROBORATION OF DR. TILSETH’S REDUCTION TO PRACTICE STORY
`[CONTINUED]
`In re Spiller, 500 F.2d 1170, 1178 (CCPA 1974) (genus -
`species)
`(“We are satisfied that the differences in the embodiments
`called for by the claims are so small that the claimed
`invention would have been obvious.”).
`In re Stryker, 435 F.2d 1340, 1341 (CCPA 1971) (genus -
`species).
`(“the differences between the claimed invention and the
`reference disclosure are so small”).
`In re Clarke, 356 F.2d 987, 992 (CCPA 1966)
`(anticipation/genus-species).
`In re Wakefield, 422 F.2d 897, 901 (CCPA 1970)
`(anticipation/genus-species)
`In re Schaub, 537 F.2d 509, 512 (CCPA 1976)
`(anticipation/genus-species).
`
`•
`
`•
`
`•
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 43
`
`
`
`BREIVIK II NOT ESSENTIAL
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 44
`
`
`
`EVEN WITHOUT BREIVIK II THE GROUNDS ASSERTED ARE
`SUFFICIENT TO DEMONSTRATE OBVIOUSNESS
`
`Patent Owner erroneously maintains the claims of the ‘169 patent must be found
`patentable if Breivik II is antedated. ‘169 POR at 6.
`
`• Patent Owner ignores that one or more alternative references are provided for every
`limitation for which Breivik II is cited. See, e.g.,‘169 Petition, 69-89; ‘169 Reply,
`Paper 15, p.11; ‘169 Tallon Reply Dec., EX1086 at ¶¶ 24-25.
`
`Patent Owner erroneously maintains the claims of the ‘046 patent must be found
`patentable if Breivik II is antedated. ‘046 POR at 7.
`
`• Patent Owner ignores that one or more alternative references are provided for every
`limitation for which Breivik II is cited, except for chemical denaturation and the
`combination of chemical and heat denaturation.
`
`• Patent Owner, to support its reduction to practice argument could only argue that
`“[c]hemical treatment is a standard way to destroy the activity of enzymes” and that
`“[h]eat and chemical treatment is a standard way to destroy the activity of
`enzymes.” See, e.g., ‘046 Petition, 69-88; ‘046 POR at 29-30, 37; ‘046 Tallon Reply
`Dec., EX1086 at ¶¶ 25-26.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`RIMFROST EXHIBIT 1172 SLIDE 45
`
`
`
`PETITIONER’S REFERENC